Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
Top Cited Papers
Open Access
- 11 August 2016
- journal article
- research article
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 61 (9) , 524-539
Abstract
Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT) has revised its 2009 guidelines for the management of major depressive disorder (MDD) in adults by updating the evidence and recommendations. The target audiences for these 2016 guidelines are psychiatrists and other mental health professionals. Methods: Using the question-answer format, we conducted a systematic literature search focusing on systematic reviews and meta-analyses. Evidence was graded using CANMAT-defined criteria for level of evidence. Recommendations for lines of treatment were based on the quality of evidence and clinical expert consensus. “Psychological Treatments” is the second of six sections of the 2016 guidelines. Results: Evidence-informed responses were developed for 25 questions under 5 broad categories: 1) patient characteristics relevant to using psychological interventions; 2) therapist and health system characteristics associated with optimizing outcomes; 3) descriptions of major psychotherapies and their efficacy; 4) additional psychological interventions, such as peer interventions and computer- and technology-delivered interventions; and 5) combining and/or sequencing psychological and pharmacological interventions. Conclusions: First-line psychological treatment recommendations for acute MDD include cognitive-behavioural therapy (CBT), interpersonal therapy (IPT), and behavioural activation (BA). Second-line recommendations include computer-based and telephone-delivered psychotherapy. Where feasible, combining psychological treatment (CBT or IPT) with antidepressant treatment is recommended because combined treatment is superior to either treatment alone. First-line psychological treatments for maintenance include CBT and mindfulness-based cognitive therapy (MBCT). Patient preference, in combination with evidence-based treatments and clinician/system capacity, will yield the optimal treatment strategies for improving individual outcomes in MDD.Keywords
This publication has 158 references indexed in Scilit:
- Comparative Efficacy of Seven Psychotherapeutic Interventions for Patients with Depression: A Network Meta-AnalysisPLOS Medicine, 2013
- Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trialThe Lancet, 2013
- Efficacy of peer support interventions for depression: a meta-analysisGeneral Hospital Psychiatry, 2011
- Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent DepressionArchives of General Psychiatry, 2010
- Cognitive Behavioral Therapy for Mood Disorders: Efficacy, Moderators and MediatorsPsychiatric Clinics of North America, 2010
- Depression relapse prophylaxis with Mindfulness-Based Cognitive Therapy: Replication and extension in the Swiss health care systemJournal of Affective Disorders, 2010
- Cognitive Behavioral Analysis System of Psychotherapy and Brief Supportive Psychotherapy for Augmentation of Antidepressant Nonresponse in Chronic DepressionThe REVAMP TrialAugmentation With CBASP and BSP for DepressionArchives of General Psychiatry, 2009
- The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and GynecologistsGeneral Hospital Psychiatry, 2009
- Acceptance and Commitment Therapy: Model, processes and outcomesBehaviour Research and Therapy, 2006
- The PHQ-9Journal of General Internal Medicine, 2001